scholarly journals Phenotype–genotype correlations in a pseudodominant Stargardt disease pedigree due to a novel ABCA4 deletion–insertion variant causing a splicing defect

2020 ◽  
Vol 8 (7) ◽  
Author(s):  
Di Huang ◽  
Jennifer A. Thompson ◽  
Jason Charng ◽  
Enid Chelva ◽  
Samuel McLenachan ◽  
...  
2021 ◽  
Vol 1 (1) ◽  
pp. 100005
Author(s):  
Rachael C. Heath Jeffery ◽  
Jennifer A. Thompson ◽  
Johnny Lo ◽  
Tina M. Lamey ◽  
Terri L. McLaren ◽  
...  

2021 ◽  
pp. 100259
Author(s):  
Jin Zhao ◽  
Hye Jin Kim ◽  
Keiko Ueda ◽  
Kevin Zhang ◽  
Diego Montenegro ◽  
...  

Genes ◽  
2019 ◽  
Vol 10 (6) ◽  
pp. 452 ◽  
Author(s):  
Alejandro Garanto ◽  
Lonneke Duijkers ◽  
Tomasz Z. Tomkiewicz ◽  
Rob W. J. Collin

Deep-sequencing of the ABCA4 locus has revealed that ~10% of autosomal recessive Stargardt disease (STGD1) cases are caused by deep-intronic mutations. One of the most recurrent deep-intronic variants in the Belgian and Dutch STGD1 population is the c.4539+2001G>A mutation. This variant introduces a 345-nt pseudoexon to the ABCA4 mRNA transcript in a retina-specific manner. Antisense oligonucleotides (AONs) are short sequences of RNA that can modulate splicing. In this work, we designed 26 different AONs to perform a thorough screening to identify the most effective AONs to correct splicing defects associated with c.4539+2001G>A. All AONs were tested in patient-derived induced pluripotent stem cells (iPSCs) that were differentiated to photoreceptor precursor cells (PPCs). AON efficacy was assessed through RNA analysis and was based on correction efficacy, and AONs were grouped and their properties assessed. We (a) identified nine AONs with significant correction efficacies (>50%), (b) confirmed that a single nucleotide mismatch was sufficient to significantly decrease AON efficacy, and (c) found potential correlations between efficacy and some of the parameters analyzed. Overall, our results show that AON-based splicing modulation holds great potential for treating Stargardt disease caused by splicing defects in ABCA4.


Author(s):  
Leonardo Gatticchi ◽  
Dominika Vešelényiová ◽  
Jan Miertus ◽  
Paolo Enrico Maltese ◽  
Elena Manara ◽  
...  

10.1038/ng858 ◽  
2002 ◽  
Vol 30 (4) ◽  
pp. 426-429 ◽  
Author(s):  
Franco Pagani ◽  
Emanuele Buratti ◽  
Cristiana Stuani ◽  
Regina Bendix ◽  
Thilo Dörk ◽  
...  
Keyword(s):  

1993 ◽  
Vol 13 (3) ◽  
pp. 1433-1439
Author(s):  
J A Barbas ◽  
J Galceran ◽  
L Torroja ◽  
A Prado ◽  
A Ferrús

The troponin I (TnI) gene of Drosophila melanogaster encodes a family of 10 isoforms resulting from the differential splicing of 13 exons. Four of these exons (6a1, 6a2, 6b1, and 6b2) are mutually exclusive and very similar in sequence. TnI isoforms show qualitative specificity whereby each muscle expresses a selected repertoire of them. In addition, TnI isoforms show quantitative specificity whereby each muscle expresses characteristic amounts of each isoform. In the mutant heldup3, the development of the thoracic muscles DLM, DVM, and TDT is aborted. The mutation consists of a one-nucleotide displacement of the 3' AG splice site at the intron preceding exon 6b1, resulting in the failure to produce all exon 6b1-containing TnI isoforms. These molecular changes in a constituent of the thin filaments cause the selective failure to develop the DLM, DVM, and TDT muscles while having no visible effect on other muscles wherein exon 6b1 expression is minor.


Retina ◽  
2016 ◽  
Vol 36 (9) ◽  
pp. 1741-1750 ◽  
Author(s):  
Aryeh Bernstein ◽  
Janet S. Sunness ◽  
Carol A. Applegate ◽  
Elizabeth O. Tegins
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document